Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.
Michaelsen SR, Staberg M, Pedersen H, Jensen KE, Majewski W, Broholm H, Nedergaard MK, Meulengracht C, Urup T, Villingshøj M, Lukacova S, Skjøth-Rasmussen J, Brennum J, Kjær A, Lassen U, Stockhausen MT, Poulsen HS, Hamerlik P. Michaelsen SR, et al. Neuro Oncol. 2018 Oct 9;20(11):1462-1474. doi: 10.1093/neuonc/noy103. Neuro Oncol. 2018. PMID: 29939339 Free PMC article.
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
Bashir A, Mathilde Jacobsen S, Mølby Henriksen O, Broholm H, Urup T, Grunnet K, Andrée Larsen V, Møller S, Skjøth-Rasmussen J, Skovgaard Poulsen H, Law I. Bashir A, et al. Neuro Oncol. 2019 Dec 17;21(12):1595-1606. doi: 10.1093/neuonc/noz166. Neuro Oncol. 2019. PMID: 31618420 Free PMC article.
Perspective: targeting VEGF-A and YKL-40 in glioblastoma - matter matters.
Holst CB, Pedersen H, Obara EAA, Vitting-Seerup K, Jensen KE, Skjøth-Rasmussen J, Lund EL, Poulsen HS, Johansen JS, Hamerlik P. Holst CB, et al. Cell Cycle. 2021 Apr;20(7):702-715. doi: 10.1080/15384101.2021.1901037. Epub 2021 Mar 28. Cell Cycle. 2021. PMID: 33779510 Free PMC article.
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study.
Schou Nørøxe D, Flynn A, Westmose Yde C, Østrup O, Cilius Nielsen F, Skjøth-Rasmussen J, Brennum J, Hamerlik P, Weischenfeldt J, Skovgaard Poulsen H, Lassen U. Schou Nørøxe D, et al. Mol Oncol. 2022 Jan;16(1):206-218. doi: 10.1002/1878-0261.13015. Epub 2021 Jun 25. Mol Oncol. 2022. PMID: 34018316 Free PMC article.
Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma.
Holst CB, Christensen IJ, Vitting-Seerup K, Skjøth-Rasmussen J, Hamerlik P, Poulsen HS, Johansen JS. Holst CB, et al. Neurooncol Adv. 2021 Jun 1;3(1):vdab072. doi: 10.1093/noajnl/vdab072. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34286278 Free PMC article.
61 results